Evidence map›Paper›PMID 23229478›Full record

ArticleAntimicrobial agents and chemotherapy2013

Emergence of Klebsiella pneumoniae Coharboring KPC and VIM Carbapenemases in Colombia.

L J Rojas, M F Mojica, V M Blanco, A Correa, M C Montealegre, E De La Cadena, J J Maya, R D Camargo, J P Quinn, M V Villegas

Abstract readCase ReportsLetter
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Microbial drug resistance (Larchmont, N.Y.) · 2022
    Article
  5. Occurrence ofInternational journal of microbiology · 2019
    Article
  6. Molecular Characterization ofThe open microbiology journal · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Observational
  13. Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

L J Rojas
M F Mojica
V M Blanco
A Correa
M C Montealegre
E De La Cadena
J J Maya
R D Camargo
J P Quinn
M V Villegas

Funding

Vector/Host-Parasite Interface of Leishmaniasis in ColombiaD43TW006589 · FIC · YALE UNIVERSITY · PI GORE SARAVIA, NANCY, TSCHUDI, CHRISTIAN · 2003 to 2024
$4.3M
FIC NIH HHS D43 TW006589
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesColombiaCross InfectionFemaleHumansKlebsiella InfectionsKlebsiella pneumoniaeMeropenemPneumonia, BacterialStrokeThienamycinsAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase KPC-2, Klebsiella pneumoniaebeta-LactamasescarbapenemaseMeropenemThienamycins

Identifiers

PMID23229478
PMCPMC3553742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.